Official Publications MaaT Pharma

Equities

Real-time Euronext Paris Other stock markets 06:31:35 2024-04-30 am EDT			5-day change	1st Jan Change
9.44 ^EUR	+0.85%		+8.01%	+35.24%

Apr. 15	MaaT Pharma: positive data in graft-versus-host disease	CF
Apr. 15	MaaT Pharma Presents Positive 18-Month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event	CI

Combined general shareholders meeting	Apr. 21	CO
Universal registration document	Apr. 01	CO
Annual results	Mar. 27	CO
Annual results	Mar. 27	CO
Changes in management and corporate officers	Mar. 20	CO
Changes in management and corporate officers	Mar. 20	CO
Provisional calendar	Mar. 06	CO
Provisional calendar	Mar. 06	CO
Monthly statement on voting rights	Feb. 28	CO
Monthly statement on voting rights	Feb. 28	CO
Monthly statement on voting rights	Jan. 30	CO
Monthly statement on voting rights	Jan. 30	CO
Shareholder letter	Jan. 30	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	Jan. 17	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	Jan. 16	CO
Monthly statement on voting rights	Dec. 30	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	Dec. 30	CO
Monthly statement on voting rights	Nov. 29	CO
Monthly statement on voting rights	Nov. 29	CO
3rd quarter turnover	Nov. 08	CO
3rd quarter turnover	Nov. 08	CO
Monthly statement on voting rights	23-10-30	CO
Monthly statement on voting rights	23-10-30	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-28	CO
1st-half-year results	23-09-25	CO